Entity > Corporation > US > New York City New York > Amarin Corporation
About Amarin Corporation
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Amarin Corporation
| Company Attribute | Value |
| Name | Amarin Corporation |
| Url | amarincorp |
| Wikipedia | wikipedia |
| Wikidata | wikidata |
Amarin Corporation
New York City, US
5 May 2024
Amarin Corporation
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://amarincorp.com/
Amarin, a rapidly growing pharmaceutical cardiovascular care company, develops and markets treatments for cardiovascular disease.
Rich Sitelinks
People Also Ask
https://finance.yahoo.com › quote › AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular ...
News
https://en.wikipedia.org › wiki › Amarin_Corporation
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey.
https://www.nasdaq.com › Market Activity › Stocks
Discover real-time Amarin Corporation plc (AMRN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
https://www.cnbc.com › quotes › AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve ...
https://www.marketwatch.com › ... › Quotes › ADRs
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on ...
Related Searches
Amarin corporation owner
amarin vascepa
Amarin corporation stock
Knowledge Panel
Amarin Corporation (Company)
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
-
Stock price : AMRN (NASDAQ) $0.91 -0.01 (-0.87%)May 3, 4:00 PM EDT - Disclaimer
-
Headquarters : Dublin, Ireland
-
CEO : Karim Mikhail (Aug 1, 2021–)
-
Revenue : 614.1 million USD (2020)
-
Subsidiaries : Amarin Pharma, Inc., MORE
-
Founded : March 1, 1989